Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: A systematic review and meta-analysis

The Lancet Oncology

Volumn 15, Issue 9, 2014, Pages 1027-1038

  Patel, Samir H ^a   Wang, Zhen ^b   Wong, William W ^a   Murad, Mohammad Hassan ^b   Buckey, Courtney R ^a   Mohammed, Khaled ^b   Alahdab, Fares ^b   Altayar, Osama ^b   Nabhan, Mohammed ^b   Schild, Steven E ^a   Foote, Robert L ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ARTICLE; CHARGED PARTICLE THERAPY; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE CONTROL; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; META ANALYSIS; NOSE CAVITY ADENOCARCINOMA; NOSE CAVITY CANCER; NOSE CAVITY SQUAMOUS CELL CARCINOMA; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PARANASAL SINUS ADENOCARCINOMA; PARANASAL SINUS CANCER; PARANASAL SINUS SQUAMOUS CELL CARCINOMA; PHOTON THERAPY; PRIORITY JOURNAL; PROTON THERAPY; RADIOTHERAPY; SALIVARY GLAND CANCER; SINONASAL UNDIFFERENTIATED CARCINOMA; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; UNDIFFERENTIATED CARCINOMA; ADULT; AGED; ALPHA RADIATION; BRACHYTHERAPY; FEMALE; MALE; MIDDLE AGED; MORTALITY; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; PATHOLOGY; PHOTON; PROCEDURES; PROGNOSIS; RADIATION DOSE; RADIATION RESPONSE; RISK ASSESSMENT; SURVIVAL RATE; THERAPEUTIC USE; TREATMENT OUTCOME;

ADULT; AGED; ALPHA PARTICLES; BRACHYTHERAPY; COHORT STUDIES; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; PHOTONS; PROGNOSIS; RADIATION DOSAGE; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84904993837     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70268-2     Document Type: Article

References (58)

1. Turner JH, Reh DD Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 2012, 34:877-885.
2. van de Water TA, Bijl HP, Schilstra C, Pijls-Johannesma M, Langendijk JA The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature. Oncologist 2011, 16:366-377.
3. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001, 92:3012-3029.
4. Moher D, Liberati A, Tetzlaff J, Altman DG Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
5. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses (accessed May 22, 2014). http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
6. Clopper CJ, Pearson ES The use of confidence of fiducial limits illustrated in the case of the binomial. Biometrika 1934, 26:404-413.
7. DerSimonian R, Laird N Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
8. Altman DG, Bland JM Interaction revisited: the difference between two estimates. BMJ 2003, 326:219.
9. Higgins JP, Thompson SG Controlling the risk of spurious findings from meta-regression. Stat Med 2004, 23:1663-1682.
10. Duval S, Tweedie R Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
11. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med 2007, 26:4544-4562.
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
13. Egger M, Davey Smith G, Schneider M, Minder C Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
14. Allen MW, Schwartz DL, Rana V, et al. Long-term radiotherapy outcomes for nasal cavity and septal cancers. Int J Radiat Oncol Biol Phys 2008, 71:401-406.
15. Al-Mamgani A, Monserez D, Rooij P, Verduijn GM, Hardillo JA, Levendag PC Highly-conformal intensity-modulated radiotherapy reduced toxicity without jeopardizing outcome in patients with paranasal sinus cancer treated by surgery and radiotherapy or (chemo)radiation. Oral Oncol 2012, 48:905-911.
16. Buiret G, Montbarbon X, Fleury B, et al. Inverted papilloma with associated carcinoma of the nasal cavity and paranasal sinuses: treatment outcomes. Acta Otolaryngol 2012, 132:80-85.
17. Castro JR, Reimers MM Charged particle radiotherapy of selected tumors in the head and neck. Int J Radiat Oncol Biol Phys 1988, 14:711-720.
18. Christopherson K, Werning JW, Malyapa RS, Morris CG, Mendenhall WM Radiotherapy for sinonasal undifferentiated carcinoma. Am J Otolaryngol 2014, 35:141-146.
19. Combs SE, Konkel S, Thilmann C, Debus J, Schulz-Ertner D Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses. Strahlenther Onkol 2007, 183:63-68.
20. Daly ME, Chen AM, Bucci MK, et al. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 2007, 67:151-157.
21. Demizu Y, Fujii O, Terashima K, et al. Particle therapy for mucosal melanoma of the head and neck: a single-institution retrospective comparison of proton and carbon ion therapy. Strahlenther Onkol 2014, 190:186-191.
22. Dirix P, Vanstraelen B, Jorissen M, Vander Poorten V, Nuyts S Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy. Int J Radiat Oncol Biol Phys 2010, 78:998-1004.
23. Duprez F, Madani I, Morbee L, et al. IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival. Int J Radiat Oncol Biol Phys 2012, 83:252-259.
24. Fitzek MM, Thornton AF, Varvares M, et al. Neuroendocrine tumors of the sinonasal tract: results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer 2002, 94:2623-2634.
25. Fukumitsu N, Okumura T, Mizumoto M, et al. Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam. Int J Radiat Oncol Biol Phys 2012, 83:704-711.
26. Guan X, Wang X, Liu Y, Hu C, Zhu G Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT. Oral Oncol 2013, 49:60-65.
27. Herr MW, Sethi RKV, Meier JC, et al. Esthesioneuroblastoma: an update on the Massachusetts eye and ear infirmary and Massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. J Neurol Surg B Skull Base 2014, 75:58-64.
28. Hinerman RW, Indelicato DJ, Morris CG, et al. Radiotherapy with or without surgery for maxillary sinus squamous cell carcinoma: should the clinical N0 neck be treated?. Am J Clin Oncol 2011, 34:483-487.
29. Homma A, Oridate N, Suzuki F, et al. Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience. Cancer 2009, 115:4705-4714.
30. Hoppe BS, Nelson CJ, Gomez DR, et al. Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys 2008, 72:763-769.
31. Hoppe BS, Wolden SL, Zelefsky MJ, et al. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity. Head Neck 2008, 30:925-932.
32. Jang NY, Wu HG, Park CI, et al. Definitive radiotherapy with or without chemotherapy for T3-4N0 squamous cell carcinoma of the maxillary sinus and nasal cavity. Jpn J Clin Oncol 2010, 40:542-548.
33. Jensen AD, Nikoghosyan AV, Ecker S, Ellerbrock M, Debus J, Munter MW Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity. Radiat Oncol 2011, 6:30.
34. Jimbo H, Kamata S, Miura K, et al. Operative management of skull base malignant tumors arising from the nasal cavity and paranasal sinus: recent strategies used in 25 cases. Neurol Med Chir (Tokyo) 2010, 50:20-26.
35. Kaur G, Kane AJ, Sughrue ME, et al. The prognostic implications of Hyam's subtype for patients with Kadish stage C esthesioneuroblastoma. J Clin Neurosci 2013, 20:281-286.
36. Luo SQ, Shi M, Wang JH, Li JP, Xiao F, Li DM Prognostic analysis of patients with locally advanced nasal cavity and sino-nasal carcinoma treated by radiotherapy. Chin J Cancer Prev Treat 2011, 18:296-299. (in Chinese).
37. McLean JN, Nunley SR, Klass C, Moore C, Muller S, Johnstone PA Combined modality therapy of esthesioneuroblastoma. Otolaryngol Head Neck Surg 2007, 136:998-1002.
38. Mendenhall WM, Amdur RJ, Morris CG, et al. Carcinoma of the nasal cavity and paranasal sinuses. Laryngoscope 2009, 119:899-906.
39. Moreno MA, Roberts DB, Kupferman ME, et al. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the MD Anderson Cancer Center. Cancer 2010, 116:2215-2223.
40. Okano S, Tahara M, Zenda S, et al. Induction chemotherapy with docetaxel, cisplatin and S-1 followed by proton beam therapy concurrent with cisplatin in patients with T4b nasal and sinonasal malignancies. Jpn J Clin Oncol 2012, 42:691-696.
41. Rajapurkar M, Thankappan K, Sampathirao LMCS, Kuriakose MA, Iyer S Oncologic and functional outcome of the preserved eye in malignant sinonasal tumors. Head Neck 2013, 35:1379-1384.
42. Slevin NJ, Irwin CJ, Banerjee SS, Gupta NK, Farrington WT Olfactory neural tumours: the role of external beam radiotherapy. J Laryngol Otol 1996, 110:1012-1016.
43. Takeda A, Shigematsu N, Suzuki S, et al. Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity. Int J Radiat Oncol Biol Phys 1999, 44:599-605.
44. Thariat J, Poissonnet G, Marcy PY, et al. Effect of surgical modality and hypofractionated split-course radiotherapy on local control and survival from sinonasal mucosal melanoma. Clin Oncol (R Coll Radiol) 2011, 23:579-586.
45. Truong MT, Kamat UR, Liebsch NJ, et al. Proton radiation therapy for primary sphenoid sinus malignancies: treatment outcome and prognostic factors. Head Neck 2009, 31:1297-1308.
46. Uchida D, Shirato H, Onimaru R, et al. Long-term results of ethmoid squamous cell or undifferentiated carcinoma treated with radiotherapy with or without surgery. Cancer J 2005, 11:152-156.
47. Van Der Laan TP, Bij HP, Van Hemel BM, et al. The importance of multimodality therapy in the treatment of sinonasal neuroendocrine carcinoma. Eur Arch Otorhinolaryngol 2013, 270:2565-2568.
48. Van Gerven L, Jorissen M, Nuyts S, Hermans R, Vander Poorten V Long-term follow-up of 44 patients with adenocarcinoma of the nasal cavity and sinuses primarily treated with endoscopic resection followed by radiotherapy. Head Neck 2011, 33:898-904.
49. Weber DC, Chan AW, Lessell S, et al. Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons/protons. Radiother Oncol 2006, 81:243-249.
50. Wiegner EA, Daly ME, Murphy JD, et al. Intensity-modulated radiotherapy for tumors of the nasal cavity and paranasal sinuses: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2012, 83:243-251.
51. Wu AJ, Gomez J, Zhung JE, et al. Radiotherapy after surgical resection for head and neck mucosal melanoma. Am J Clin Oncol 2010, 33:281-285.
52. Yoshida E, Aouad R, Fragoso R, et al. Improved clinical outcomes with multi-modality therapy for sinonasal undifferentiated carcinoma of the head and neck. Am J Otolaryngol 2013, 34:658-663.
53. Zenda S, Kawashima M, Nishio T, et al. Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study. Int J Radiat Oncol Biol Phys 2011, 81:135-139.
54. Zenda S, Kohno R, Kawashima M, et al. Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 2011, 81:1473-1478.
55. Ioannidis JP, Trikalinos TA The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ 2007, 176:1091-1096.
56. Fried DV, Zanation AM, Huang B, et al. Patterns of local failure for sinonasal malignancies. Pract Radiat Oncol 2013, 3:e113-e120.
57. Ojo B, Genden EM, Teng MS, Milbury K, Misiukiewicz KJ, Badr H A systematic review of head and neck cancer quality of life assessment instruments. Oral Oncol 2012, 48:923-937.
58. Trask PC, Hsu MA, McQuellon R Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance. Cancer J 2009, 15:435-440.